Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Esposito Pamela Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 18,600 shares @ $20.01, valued at $372.2k
Exercised 13,600 options to buy @ $3.3, valued at $44.9k
Exercised 5,000 options to buy @ $15.5, valued at $77.5k
08/15/2023 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 1,400 shares @ $20, valued at $28k
Exercised 1,400 options to buy @ $3.3, valued at $4.6k
07/11/2023 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 17,923 shares @ $21.63, valued at $387.7k
Sold 2,077 shares @ $21.12, valued at $43.9k
Exercised 15,000 options to buy @ $3.3, valued at $49.5k
Exercised 5,000 options to buy @ $15.5, valued at $77.5k
07/10/2023 144 Form 144 - Report of proposed sale of securities:
05/18/2023 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 5,966 shares @ $18.05, valued at $107.7k
04/04/2023 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 40,000 shares @ $0
Granted 60,000 options to buy @ $17.66, valued at $1.1M
12/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Esposito Pamela (Director) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Granted 12,000 options to buy @ $14.18, valued at $170.2k
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2022 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 22,750 shares @ $0
Granted 34,125 options to buy @ $18.26, valued at $623.1k
08/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/19/2021 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 4,600 shares @ $33.37, valued at $153.5k
Exercised 4,600 options to buy @ $1.01, valued at $4.6k
07/19/2021 4/A Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Sold 20,000 shares @ $45.02, valued at $900.4k
Sold 29,273 shares @ $43.58, valued at $1.3M
Sold 600 shares @ $43.24, valued at $25.9k
Sold 5,127 shares @ $42.38, valued at $217.3k
Exercised 20,000 options to buy @ $1.01, valued at $20.2k
Exercised 29,273 options to buy @ $1.01, valued at $29.6k
Exercised 5,727 options to buy @ $1.01, valued at $5.8k
06/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/28/2020 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Exercised 50,704 options to buy @ $1.75, valued at $88.7k
12/15/2020 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Exercised 12,590 options to buy @ $3.3, valued at $41.5k
10/16/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/09/2020 4 Esposito Pamela (Director) has filed a Form 4 on Kymera Therapeutics, Inc.
Txns: Granted 40,127 options to buy @ $29.55, valued at $1.2M
09/09/2020 3 Esposito Pamela (Director) has filed a Form 3 on Kymera Therapeutics, Inc.
09/01/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/02/2020 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 85,450 options to buy @ $9.78, valued at $835.7k
12/23/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/03/2019 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 75,750 options to buy @ $15.5, valued at $1.2M
12/17/2018 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Exercised 87,000 options to buy @ $1.75, valued at $152.3k
07/26/2018 4 Esposito Pamela (Chief Business Officer) has filed a Form 4 on Replimune Group, Inc.
Txns: Granted 70,000 options to buy @ $15, valued at $1.1M
07/19/2018 3 Esposito Pamela (Chief Business Officer) has filed a Form 3 on Replimune Group, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy